Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Venous Thrombosis 2 Venous Thromboembolism 2 Pulmonary Embolism 2 Neoplasms 2 Urinary Bladder Neoplasms 1 Thrombosis 1 Thromboembolism 1 Stroke 1 Soft Tissue Neoplasms 1 Sarcoma 1 Multiple Myeloma 1 Lymphoma 1 Leukemia 1 Hemorrhage 1 Hematologic Neoplasms 1 Anastomotic Leak 1

Interventions

Nutrition Assessment 3 Transcranial Direct Current Stimulation 2 urinastatin 1 X-Rays 1 Thrombectomy 1 Saline Solution 1 Resistance Training 1 Phenylephrine 1 Palliative Care 1 Norepinephrine 1 Music Therapy 1 Massage 1 Lysine Acetyltransferase 5 1 Extracorporeal Shockwave Therapy 1 Exergaming 1 Enoxaparin 1 Dialectical Behavior Therapy 1 Cerebral Angiography 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Stroke × Enoxaparin × Clear all

NCT01763606 2020-08-14

Enoxaparin Versus Aspirin in Patients With Cancer and Stroke

Memorial Sloan Kettering Cancer Center

Phase NA Completed

20 enrolled 11 charts

Stroke

Data powered by HemOnc (CC BY 4.0) Colophon ⚡